Natco Pharma shares surged 5% to Rs 1,569 after filing an ANDA with the US FDA for a generic cancer drug. The company aims for 180 days of marketing exclusivity.
Nykaa shares jump 8% to fresh 52-week high after unveiling FY30 roadmap; targets up to 3x revenue growth
Nykaa’s parent company, FSN E-Commerce Ventures, saw its shares surge over 8% to a 52-week high after unveiling an ambitious FY30 vision. The company aims